Introduction
Choosing where to receive cancer treatment is one of the most consequential decisions a patient and their family will make. The difference between a generalist hospital and a specialist center with deep experience in your specific cancer type can be significant — in outcomes, in access to the latest therapies, and in the quality of multidisciplinary care.
This guide provides an honest overview of the world's leading cancer centers, a practical framework for choosing the right hospital in Shanghai, and an introduction to some of Shanghai's most experienced oncology specialists. It also explains how China Medical Concierge Shanghai (CMCS) helps international patients navigate this landscape — remotely, from the first inquiry.
Section 1 — The World's Leading Cancer Centers
The following institutions are consistently recognized among the world's most advanced cancer centers. Each has particular areas of depth, and understanding their strengths can help patients think clearly about where their specific diagnosis is best addressed.
🇺🇸 United States
MD Anderson Cancer Center (Houston, Texas) is consistently ranked among the top cancer hospitals in the world. It is particularly recognized for leukemia, melanoma, lung cancer, and head and neck cancers, and operates one of the world's largest oncology clinical trial programs.
Memorial Sloan Kettering Cancer Center (New York) is a global leader in solid tumor surgery, genomic medicine, and cancer biology research. Its surgical oncology programs — particularly for gastrointestinal, breast, and urological cancers — are among the most experienced in the world.
Mayo Clinic (Rochester, Minnesota) is distinguished by its integrated multidisciplinary model, bringing together specialists across disciplines for complex and rare cancer cases. It is particularly strong in rare tumors and cases requiring coordinated multi-specialty input.
Johns Hopkins Hospital (Baltimore, Maryland) is internationally recognized for pancreatic cancer surgery (the Whipple procedure), neuro-oncology, and cancer genetics research.
🇫🇷 France
Gustave Roussy (Villejuif, Paris) is Europe's largest cancer campus and a global reference center for radiation oncology, hematological malignancies, and early-phase clinical trials. For patients already in the European system, Gustave Roussy represents one of the highest standards of multidisciplinary oncology care available.
→ For patients from Gustave Roussy considering a Shanghai second opinion or treatment, see our dedicated guide: Gustave Roussy Patients: How to Access Shanghai’s Top Cancer Specialists in 2026.
🇩🇪 Germany
Heidelberg University Hospital and the affiliated German Cancer Research Center (DKFZ) are among Europe's leading institutions for precision oncology, proton therapy, and translational cancer research. Charité Berlin is recognized for neuro-oncology and hematological malignancies.
🇬🇧 United Kingdom
The Royal Marsden (London and Surrey) is the UK's leading specialist cancer hospital, with particular strength in breast cancer, urological oncology, and pediatric oncology. It operates in close partnership with the Institute of Cancer Research.
🇯🇵 Japan
National Cancer Center Japan (Tokyo) is Asia's most established dedicated cancer institution, with particular expertise in gastric cancer, colorectal cancer, and endoscopic treatment. Japan's systematic approach to cancer screening and early detection is internationally recognized.
🇸🇬 Singapore
National Cancer Centre Singapore serves as Southeast Asia's primary regional oncology referral center, offering JCI-accredited care in a fully English-language environment. It is a natural first point of contact for patients across Southeast Asia before considering further referral to Shanghai or other centers.
Section 2 — Choosing the Right Cancer Hospital in Shanghai
Shanghai is home to several of China's — and Asia's — most experienced cancer centers. The right choice depends primarily on your cancer type, as different hospitals have developed particular depth in different specialties.
Key Factors in Choosing a Shanghai Cancer Hospital
- Specialty match: The most important factor. A hospital with the highest annual volume in your specific cancer type will have the deepest clinical experience.
- Multidisciplinary tumor board (MDT) capability: Top Shanghai hospitals hold regular MDT meetings where surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists review complex cases together.
- Access to innovative therapies: Some hospitals are leading centers for specific clinical trials or newly approved therapies such as CAR-T, targeted agents, or immunotherapy combinations.
- International patient services: Availability of English-speaking coordinators, international departments, and experience with overseas patients.
Fudan University Shanghai Cancer Center (FUSCC 复旦大学附属肿瘤医院)
FUSCC is Shanghai's dedicated cancer specialty hospital and one of China's highest-volume oncology centers. It is particularly strong in breast cancer, head and neck cancers, gynecological oncology, thoracic oncology, and radiation therapy. Its breast cancer program is among the most experienced in Asia, and its radiation oncology department handles a broad range of complex cases.
Fudan University Zhongshan Hospital (复旦大学附属中山医院)
Zhongshan Hospital is one of China's premier comprehensive hospitals, with particular oncology strength in hepatocellular carcinoma (liver cancer), pancreatic cancer, colorectal cancer, and lung cancer. Its hepatobiliary surgery department handles one of the highest volumes of liver cancer cases in the world. The hospital's cardiac surgery and multidisciplinary capabilities also make it well suited for patients with complex comorbidities alongside their cancer diagnosis.
→ See also: A Father’s Second Chance at Life — Hepatobiliary Surgery with Dr. Jian Zhou at Zhongshan Hospital.
Shanghai Jiao Tong University Ruijin Hospital (瑞金医院)
Ruijin Hospital is China's leading center for hematological malignancies, including lymphoma, leukemia, and multiple myeloma. Its hematology department, led by internationally recognized researchers, is at the forefront of CAR-T cell therapy development in China. Ruijin is also a strong center for gastric cancer surgery and endocrine oncology.
Fudan University Huashan Hospital (华山医院)
Huashan Hospital is Shanghai's leading center for neuro-oncology and brain tumor surgery. Its neurosurgery department handles a high volume of complex intracranial tumors, including gliomas, meningiomas, and skull base tumors, with advanced intraoperative monitoring and navigation technology.
→ See also: Dr. Zhiyong Qin — Neurosurgery & Radiosurgery Expert at Huashan Hospital.
Shanghai Chest Hospital (上海市胸科医院)
Shanghai Chest Hospital is China's leading dedicated thoracic specialty hospital, with particular expertise in lung cancer, esophageal cancer, and mediastinal tumors. Its thoracic surgery and oncology departments handle one of the highest volumes of lung cancer cases in Asia.
→ See also: A Lung Cancer Miracle at Shanghai Chest Hospital.
Shanghai Ninth People's Hospital (上海第九人民医院)
The Ninth People's Hospital is China's leading center for oral and maxillofacial surgery, including head and neck tumor reconstruction, jaw tumors, and salivary gland malignancies. Its maxillofacial oncology program combines surgical expertise with reconstructive capability at a scale unmatched in most countries.
Section 3 — Shanghai's Top Oncology Specialists
The following specialists represent some of Shanghai's most experienced oncology practitioners. CMCS works with patients to identify the right specialist for each individual case based on diagnosis, tumor characteristics, and treatment history.
Hepatobiliary Oncology
Prof. Fan Jia (樊嘉) — Zhongshan Hospital, Fudan University. One of China's most recognized liver cancer surgeons, Prof. Fan has led Zhongshan's hepatobiliary surgery department to become one of the highest-volume liver cancer surgical centers in the world. His work spans liver resection, liver transplantation for cancer, and the development of minimally invasive hepatic surgery techniques.
Prof. Jian Zhou (周俣) — Zhongshan Hospital, Fudan University. A leading figure in laparoscopic liver surgery and hepatocellular carcinoma management, Prof. Zhou is recognized for his expertise in minimally invasive hepatic resection and complex liver tumor cases.
→ Read a patient case: A Father’s Second Chance at Life with Dr. Jian Zhou.
Hematological Oncology
Prof. Zhao Weili (赵维莎) — Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Prof. Zhao is one of China's foremost authorities on lymphoma and leukemia, and a leading researcher in CAR-T cell therapy for hematological malignancies. Her department at Ruijin is at the forefront of innovative cellular immunotherapy in China.
Breast Cancer
Prof. Shen Kunwei (沈坤炮) — Ruijin Hospital. A leading breast surgical oncologist, Prof. Shen is recognized for his expertise in breast-conserving surgery, sentinel lymph node techniques, and the multidisciplinary management of complex breast cancer cases.
Neuro-Oncology
Dr. Zhiyong Qin (秦智勇) — Huashan Hospital, Fudan University. A specialist in neurosurgery and radiosurgery, Dr. Qin has extensive experience in the treatment of brain tumors, including gliomas and meningiomas, using both open surgical and stereotactic radiosurgery approaches.
→ Read Dr. Qin’s full profile.
Thoracic Oncology
Shanghai Chest Hospital's thoracic surgery and oncology teams are among China's most experienced in lung cancer, esophageal cancer, and minimally invasive thoracic procedures. CMCS can identify the most appropriate specialist based on your specific diagnosis and staging.
→ Read a lung cancer patient story at Shanghai Chest Hospital.
Section 4 — The Advantages of Shanghai's Multidisciplinary Tumor Boards (MDT)
What Is an MDT?
A Multidisciplinary Tumor Board (MDT) — also called a tumor conference or multidisciplinary team meeting — brings together specialists from multiple disciplines to review a patient's case collectively and agree on the optimal treatment plan. A typical oncology MDT includes a surgical oncologist, medical oncologist, radiation oncologist, diagnostic radiologist, and pathologist.
For complex cancer cases, MDT review is widely recognized as the gold standard of care. It reduces the risk of any single specialist's perspective dominating the treatment decision, and ensures that all relevant options — surgery, systemic therapy, radiation, or a combination — are considered together.
Shanghai's MDT Strengths
Shanghai's leading cancer hospitals hold regular, structured MDT meetings for complex cases. Several features make these particularly valuable for international patients:
- High case volume: Shanghai's top hospitals see an extraordinary number of cancer cases annually. This means that even rare tumor types are reviewed regularly, and the MDT team has genuine accumulated experience with unusual presentations.
- Depth of specialist expertise: Each MDT participant is typically a senior specialist in their field, not a generalist. The surgical oncologist, medical oncologist, and radiation oncologist at a Shanghai MDT will each have deep subspecialty experience.
- Integration of innovative therapies: Shanghai MDTs routinely consider clinical trial eligibility, newly approved targeted agents, and immunotherapy combinations as part of their deliberations — including therapies approved in China that may not yet be available in other markets.
- TCM integration: Selected Shanghai hospitals incorporate Traditional Chinese Medicine specialists into their MDT process for supportive care planning, particularly in oncology rehabilitation and symptom management.
How CMCS Facilitates MDT Access for International Patients
For international patients, accessing an MDT at a Shanghai hospital requires preparation and coordination. CMCS manages this process end to end:
- Compiling and translating your complete medical records into the format required by the receiving hospital
- Submitting your case for MDT review and confirming the meeting schedule
- Translating the MDT's conclusions and treatment recommendations into English
- Facilitating a follow-up consultation with the lead specialist to discuss the MDT outcome
- Coordinating next steps — whether remote treatment planning, travel to Shanghai, or communication back to your home-country oncology team
Section 5 — How to Access Shanghai's Oncology Specialists Through CMCS
The process of connecting with a Shanghai cancer specialist through CMCS is designed to be straightforward, remote-first, and fully coordinated.
- Initial inquiry: Contact CMCS with a brief summary of your diagnosis and your key questions. No obligation at this stage.
- Case review: Your CMCS case manager reviews your records and identifies the most appropriate Shanghai specialist and hospital for your case.
- Remote pre-consultation: We arrange a written or video consultation with the Shanghai specialist before any travel is considered.
- Treatment decision: You receive the specialist's assessment in English and decide how to proceed — with full support from your CMCS case manager.
- Travel and in-hospital coordination: If you choose to come to Shanghai, CMCS handles every aspect of your visit.
→ For a detailed walkthrough of the process, see: How to Access Shanghai’s Top Cancer Specialists: A Step-by-Step Guide.
→ For information on China-exclusive cancer therapies including Savolitinib and CAR-NKT, see: China-Exclusive Cancer Therapies in 2026.
→ For a broader comparison of medical destinations across Asia and Europe, see: Choosing the Right Country for Medical Care in 2026.
Begin Your Oncology Consultation
Shanghai's cancer specialists are among the most experienced in the world for a range of tumor types. CMCS exists to make their expertise accessible to international patients — with full remote coordination, professional translation, and end-to-end support.
Contact us to begin your case review.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS — China Medical Concierge Shanghai. Connecting international patients with Shanghai’s leading oncology specialists, remotely and in person.
0 comments